Scientific trials on the KALME Range
The most significant aggravating factor in Rosacea is sun exposure. The importance of sun blocking is highlighted by Murphy from the Department of Dermatology, Beaumont Hospital, Dublin, Ireland who concludes after research carried out in 2004 ¹ that
“The general consensus among clinicians is that rosacea is a photo aggravated disorder. Pathophysiologic processes induced by UV radiation, which are processes similar to those seen in photoageing, contribute to the signs and symptoms of rosacea… In addition to topical and oral therapy for rosacea, clinicians should recommend that patients use sunscreens or sunblocks (inorganic chemicals such as zinc oxide).”
KALME contains a unique micronised Zinc Oxide which offers highly effective protection over the UVA and UVB bandwidths of all sun filters. Zinc Oxide is not used by other skin care ranges because it is difficult and expensive to make transparent. KALME’s Zinc Oxide was the first to be able to achieve this SPF while remaining transparent by avoiding “light scatter” which gives most zinc oxide creams the white face look.
Unlike all other sun screens it also has a beneficial effect on the skin as an anti inflammatory mineral.
The research was carried out on people with normal skin. KALME was found to have an SPF in excess SPF of 25 on all testers making it a certified SPF 25..
¹ Ultraviolet light and rosacea. Cutis. 2004 Sep;74(3 Suppl):13-6, 32-4.
² Carried out by Euroderm Research Ltd. (13th July 2007)
The research was carried out by Derma Consultant in Germany which is fully accredited and regulatory recognised laboratory using qualified dermatologists.
Fifty people were selected for the trial, 20 had normal skin, 11 had eczema, 4 suffered with allergies and 15 had sensitive skin. Each product in the KALME range was then individually applied and left on the skin to study for any signs of irritation. Each formulation caused no irritation, even to very sensitive skin.